| scholarly article | Q13442814 |
| P50 | author | James K. Min | Q16213661 |
| James Januzzi | Q63144011 | ||
| P2093 | author name string | Jagmeet P Singh | |
| Jackie Szymonifka | |||
| Bryan Wai | |||
| Quynh A Truong | |||
| Wai-ee Thai | |||
| Roderick C Deaño | |||
| Neal A Chatterjee | |||
| P2860 | cites work | Mechanisms activated by kidney disease and the loss of muscle mass | Q34453602 |
| Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate | Q34557258 | ||
| Cystatin C: an improved estimator of glomerular filtration rate? | Q34616081 | ||
| Coronary sinus biomarker sampling compared to peripheral venous blood for predicting outcomes in patients with severe heart failure undergoing cardiac resynchronization therapy: the BIOCRT study | Q34622450 | ||
| AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part III: intraventricular conduction disturbances: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Comm | Q34961756 | ||
| Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers | Q35927436 | ||
| Cardiac resynchronization therapy: Part 1--issues before device implantation | Q36344631 | ||
| Cystatin C identifies patients with stable chronic heart failure at increased risk for adverse cardiovascular events | Q36345739 | ||
| Multidisciplinary care of patients receiving cardiac resynchronization therapy is associated with improved clinical outcomes | Q36790189 | ||
| Cardiac resynchronization therapy in CKD: a systematic review | Q37065585 | ||
| 20 years of cardiac resynchronization therapy | Q38246205 | ||
| Device-measured physical activity versus six-minute walk test as a predictor of reverse remodeling and outcome after cardiac resynchronization therapy for heart failure | Q39228602 | ||
| Cystatin C and NT-proBNP, a powerful combination of biomarkers for predicting cardiovascular mortality in elderly patients with heart failure: results from a 10-year study in primary care | Q39874478 | ||
| Cystatin-C and mortality in elderly persons with heart failure. | Q40454237 | ||
| Renal function as a predictor of outcome in a broad spectrum of patients with heart failure | Q43500856 | ||
| Diagnostic accuracies of plasma creatinine, cystatin C, and glomerular filtration rate calculated by the Cockcroft-Gault and Levey (MDRD) formulas | Q44484527 | ||
| Cystatin C as a predictor of mortality and cardiovascular morbidity after cardiac resynchronization therapy | Q45139333 | ||
| Cystatin C, a novel measure of renal function, is an independent predictor of cardiac events in patients with heart failure | Q46757357 | ||
| Regional myocardial contractile reserve assessed by strain echocardiography and the response to cardiac resynchronization therapy. | Q50622963 | ||
| Chronic kidney disease and functional limitation in older people: health, aging and body composition study. | Q50730639 | ||
| Hyperphosphatemia aggravates cardiac fibrosis and microvascular disease in experimental uremia | Q73112310 | ||
| Proposal for a new clinical end point to evaluate the efficacy of drugs and devices in the treatment of chronic heart failure | Q74073788 | ||
| P304 | page(s) | 43-49 | |
| P577 | publication date | 2015-12-11 | |
| P1433 | published in | International Journal of Cardiology | Q2357863 |
| P1476 | title | Incremental value of cystatin C over conventional renal metrics for predicting clinical response and outcomes in cardiac resynchronization therapy: The BIOCRT study | |
| P478 | volume | 205 |
| Q48219168 | Vitamin D deficiency and functional response to CRT in heart failure patients | cites work | P2860 |
Search more.